Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 6974-6982

  Leon, Francisco ^a,c   Contractor, Nikhat ^a   Fuss, Ivan ^a   Marth, Thomas ^a   Lahey, Edward ^a   Iwaki, Shoko ^a   La Sala, Andrea ^a   Hoffmann, Victoria ^b   Strober, Warren ^a   Kelsall, Brian L ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD45RB ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3 RECEPTOR ANTIBODY; COMPLEMENT COMPONENT RECEPTOR ANTIBODY; INTERLEUKIN 12; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; ENTERITIS; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; TH1 CELL;

EID: 33750808899     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.6974     Document Type: Article

References (44)

1. Springer, T. A. 1990. Leucocyte adhesion to cells. Scand. J. Immunol. 32: 211-216.
2. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-434.
3. Springer, T. A. 1990. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu. Rev. Cell Biol. 6: 359-402.
4. Goodrum, K. J., L. L. McCormick, and B. Schneider. 1994. Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent. Infect. Immun. 62: 3102-3107.
5. Rosen, H., and S. Gordon. 1990. The role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse. Am. J. Respir. Cell. Mol. Biol. 3: 3-10.
6. Rosen, H., and S. K. Law. 1990. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr. Top. Microbiol. Immunol. 153: 99-122.
7. Kishimoto, T. K., R. S. Larson, A. L. Corbi, M. L. Dustin, D. E. Staunton, and T. A. Springer. 1989. The leukocyte integrins. Adv. Immunol. 46: 149-182.
8. Springer, T. A., and J. H. Wang. 2004. The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv. Protein Chem. 68: 29-63.
9. Petty, H. R., R. G. Worth, and R. F. Todd III. 2002. Interactions of integrins with their partner proteins in leukocyte membranes. Immunol. Res. 25: 75-95.
10. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185: 1987-1995.
11. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185: 1977-1985.
12. Claudia, M., A. Bacci, B. Silvia, R. Gaziano, A. Spreca, and L. Romani. 2002. The interaction of fungi with dendritic cells: implications for Th immunity and vaccination. Curr. Mol. Med. 2: 507-524.
13. Lee, S. H., and D. B. Corry. 2004. Homing alone? CD18 in infectious and allergic disease. Trends Mol. Med. 10: 258-262.
14. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281-1290.
15. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
16. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170: 394-399.
17. Boirivant, M., I. J. Fuss, A. Chu, and W. Strober. 1998. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188: 1929-1939.
18. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185: 317-328.
19. Bouma, G., A. Kaushiva, and W. Strober. 2002. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 123: 554-565.
20. Rosen, H., and S. Gordon. 1987. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 166: 1685-1701.
21. + T cells in the psoriatic epidermis: regulation by interleukins 4 and 12 and transforming growth factor β. Br. J. Dermatol. 147: 1118-1126.
22. Lee, E., W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, and J. G. Krueger. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199: 125-130.
23. Liu, Z., K. Geboes, H. Heremans, L. Overbergh, C. Mathieu, P. Rutgeerts, and J. L. Ceuppens. 2001. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur. J. Immunol. 31: 1550-1560.
24. Mannon, P. J., I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, et al. 2004. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351: 2069-2079.
25. Cho, S. S., C. M. Bacon, C. Sudarshan, R. C. Rees, D. Finbloom, R. Pine, and J. J. O'Shea. 1996. Activation of STAT4 by IL-12 and IFN-α: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157: 4781-4789.
26. Farrar, J. D., J. D. Smith, T. L. Murphy, and K. M. Murphy. 2000. Recruitment of Stat4 to the human interferon α/β receptor requires activated Stat2. J. Biol. Chem. 275: 2693-2697.
27. Gordon, E. J., K. J. Myers, J. P. Dougherty, H. Rosen, and Y. Ron. 1995. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 62: 153-160.
28. Huitinga, I., J. G. Damoiseaux, E. A. Dopp, and C. D. Dijkstra. 1993. Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats. Eur. J. Immunol. 23: 709-715.
29. Palmen, M. J., C. D. Dijkstra, M. B. van der Ende, A. S. Pena, and E. P. van Rees. 1995. Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin. Exp. Immunol. 101: 351-356.
30. + T cells induces psoriasis. Am. J. Pathol. 155: 145-158.
31. Hong, K., A. Chu, B. R. Ludviksson, E. L. Berg, and R. O. Ehrhardt. 1999. IL-12, independently of IFN-γ, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J. Immunol. 162: 7480-7491.
32. + T cells. Nat. Med. 3: 183-188.
33. high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174: 164-173.
34. Bernstein, C. N., A. Wajda, and J. F. Blanchard. 2005. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129: 827-836.
35. Najarian, D. J., and A. B. Gottlieb. 2003. Connections between psoriasis and Crohn's disease. J. Am. Acad. Dermatol. 48: 805-821; quiz 822-804.
36. + T cells correlates with suppression of psoriasis and colitis. Int. Immunopharmacol. 2: 653-672.
37. + Th1-like cells in vivo in the absence of IL-12 but in the presence of autoantigen. J. Immunol. 166: 4765-4772.
38. Dobrovolskaia, M. A., and S. N. Vogel. 2002. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4: 903-914.
39. Wright, S. D., S. M. Levin, M. T. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169: 175-183.
40. Perera, P. Y., T, N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert, and S. N. Vogel. 2001. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression. J. Immunol. 166: 574-581.
41. Hu, C., T. Mayadas-Norton, K. Tanaka, J. Chan, and P. Salgame. 2000. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J. Immunol. 165: 2596-2602.
42. Diamond, M. S., and T. A. Springer. 1993. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120: 545-556.
43. Lindbom, L., and J. Werr. 2002. Integrin-dependent neutrophil migration in extravascular tissue. Semin. Immunol. 14: 115-121.
44. 4-integrin in neutrophil chemotaxis. J. Cell Sci. 118: 5205-5220.